Detalhe da pesquisa
1.
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials.
Ann Oncol
; 34(11): 1025-1034, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37619846
2.
Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
Ann Oncol
; 33(6): 628-637, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35306156
3.
Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22).
Ann Surg
; 271(4): 637-645, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31356278
4.
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study.
Ann Oncol
; 31(7): 921-929, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294529
5.
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database.
Ann Oncol
; 31(4): 480-486, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32085892
6.
Evidence for a New Compact Symmetric Fission Mode in Light Thorium Isotopes.
Phys Rev Lett
; 124(20): 202502, 2020 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32501052
7.
Overcoming barriers in biomarker testing. Letter to the Editor regarding: "ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe", by A. Bayle et al.
Ann Oncol
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723866
8.
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies.
Ann Oncol
; 30(9): 1466-1471, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268130
9.
Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study.
Ann Oncol
; 30(1): 124-131, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30339194
10.
Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial.
Ann Surg Oncol
; 26(11): 3561-3567, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209667
11.
Inter-mesenteric connections between the superior and inferior mesenteric arteries for left colonic vascularization: implications for colorectal surgery.
Surg Radiol Anat
; 41(3): 255-264, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30478643
12.
Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review.
Ann Oncol
; 29(4): 835-856, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29452346
13.
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 34(1): 10-32, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307056
14.
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.
Ann Oncol
; 29(1): 133-138, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045659
15.
The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
Ann Oncol
; 29(5): 1099-1107, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438451
16.
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300.
Ann Oncol
; 29(10): 2052-2060, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30052729
17.
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.
Ann Oncol
; 29(5): 1211-1219, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438522
18.
Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial.
Ann Oncol
; 29(4): 931-937, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29365058
19.
CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification.
Ann Oncol
; 28(5): 1032-1035, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28328000
20.
What treatment in 2017 for inoperable pancreatic cancers?
Ann Oncol
; 28(7): 1473-1483, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28459988